UMMC Neuro Institute

Main Content

Recent News Stories from Neuro Institute

Click here to subscribe to our RSS News Feed

Esketamine, a new treatment for the severely depressed, is being hailed as a game-changer by researchers.

UMMC researcher’s pioneering work gives rise to new severe depression drug

Thursday, March 21, 2019

Thirty years ago, Dr. Ian Paul and a group of fellow young researchers had a hypothesis: that major depression has a connection with the brain neurotransmitter glutamate, and that drugs that block glutamate receptors would have an anti-depressive effect. It proved true, making possible the highly acclaimed drug esketamine, the first truly new depression treatment in three decades. Read More